Clinical Trial Update: Omega-3 Supplementation and Attention-deficit-hyperactivity Disorder (ADHD) [NA]

View source ↗

Summary

This document reports the completion of a clinical trial evaluating omega-3 fatty acid supplementation for Attention Deficit Hyperactivity Disorder. No efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Omega-3 fatty acid supplementation (Omega-3 fatty acids)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Attention Deficit Hyperactivity Disorder | NA | Status: COMPLETED